SNTI Earnings

Quarterly EPS
$-6.31
Q3 2024
$-0.67
Q4 2024
$-1.41
Q1 2025
$-0.56
Q2 2025
$-0.69
Q3 2025
$-0.52
Q4 2025
$-0.14
Q1 2026
$-0.41
Q2 2026
Latest Revenue17.0K
Latest Net Income-12750000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.4117.0K-12750000—+26.8%
Q1 2026-$0.1416.0K-4221000—+90.1%
Q4 2025-$0.5222.0K-14467000—+22.4%
Q3 2025-$0.690-18126000—+89.1%
Q2 2025-$0.560-14733000—+77.1%
Q1 2025-$1.410-14112000—+46.8%
Q4 2024-$0.670-610000—+55.3%
Q3 2024-$6.310-28866000-100.0%-87.8%
Q2 2024-$2.450-11203000——
Q1 2024-$2.650-12111000——
Q4 2023-$1.500-18716000——
Q3 2023-$3.36338.0K-14923000——
Senti Biosciences (SNTI) — Earnings